117 related articles for article (PubMed ID: 20544910)
1. Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan.
Gawlik KI; Durbeej M
Muscle Nerve; 2010 Jul; 42(1):30-7. PubMed ID: 20544910
[TBL] [Abstract][Full Text] [Related]
2. Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy.
Gawlik KI; Li JY; Petersén A; Durbeej M
Hum Mol Genet; 2006 Sep; 15(18):2690-700. PubMed ID: 16893907
[TBL] [Abstract][Full Text] [Related]
3. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
4. Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice.
Gawlik K; Miyagoe-Suzuki Y; Ekblom P; Takeda S; Durbeej M
Hum Mol Genet; 2004 Aug; 13(16):1775-84. PubMed ID: 15213105
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.
Bentzinger CF; Barzaghi P; Lin S; Ruegg MA
FASEB J; 2005 Jun; 19(8):934-42. PubMed ID: 15923403
[TBL] [Abstract][Full Text] [Related]
6. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
[TBL] [Abstract][Full Text] [Related]
7. CD90-positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy(3k)/dy(3k) mice.
Fukada S; Yamamoto Y; Segawa M; Sakamoto K; Nakajima M; Sato M; Morikawa D; Uezumi A; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Yamamoto H
Exp Cell Res; 2008 Jan; 314(1):193-203. PubMed ID: 17963748
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
9. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
Carmignac V; Quéré R; Durbeej M
Hum Mol Genet; 2011 Feb; 20(3):541-52. PubMed ID: 21084425
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.
Gawlik KI; Akerlund M; Carmignac V; Elamaa H; Durbeej M
PLoS One; 2010 Jul; 5(7):e11549. PubMed ID: 20657839
[TBL] [Abstract][Full Text] [Related]
12. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).
Allamand V; Guicheney P
Eur J Hum Genet; 2002 Feb; 10(2):91-4. PubMed ID: 11938437
[TBL] [Abstract][Full Text] [Related]
13. Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency.
Kuang W; Xu H; Vilquin JT; Engvall E
Lab Invest; 1999 Dec; 79(12):1601-13. PubMed ID: 10616210
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy.
Hagiwara H; Ohsawa Y; Asakura S; Murakami T; Teshima T; Sunada Y
FEBS Lett; 2006 Aug; 580(18):4463-8. PubMed ID: 16859688
[TBL] [Abstract][Full Text] [Related]
15. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy.
Pegoraro E; Mancias P; Swerdlow SH; Raikow RB; Garcia C; Marks H; Crawford T; Carver V; Di Cianno B; Hoffman EP
Ann Neurol; 1996 Nov; 40(5):782-91. PubMed ID: 8957020
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
Körner Z; Durbeej M
PLoS One; 2016; 11(1):e0146471. PubMed ID: 26731667
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice.
Dominov JA; Kravetz AJ; Ardelt M; Kostek CA; Beermann ML; Miller JB
Hum Mol Genet; 2005 Apr; 14(8):1029-40. PubMed ID: 15757977
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice.
Nevo Y; Halevy O; Genin O; Moshe I; Turgeman T; Harel M; Biton E; Reif S; Pines M
Muscle Nerve; 2010 Aug; 42(2):218-29. PubMed ID: 20589893
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of diaphragm muscle in alpha2-laminin (merosin)-deficient dy/dy dystrophic mice.
van Lunteren E; Moyer M; Leahy P
Physiol Genomics; 2006 Mar; 25(1):85-95. PubMed ID: 16368874
[TBL] [Abstract][Full Text] [Related]
20. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
